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Collagen has long been used as a material for tissue engineering due to its prevalence 
in the extracellular matrix of connective tissues. However, traditional collagen materials 
utilizing atelocollagen and acid solubilized telocollagen have lacked the mechanical 
integrity and collagen fibril density found in the in vivo state. Here, we utilize collagen 
oligomers and confined compression to forcibly remove a portion of the fluid phase 
component. Materials were created with controlled, substantially increased material 
properties, including order of magnitude increases in collagen fibril density, elastic 
modulus, compressive modulus,and resistance to proteolytic degradation. The technique 
was found to be amenable to cell encapslation, allowing the creation of viable 
cellularized high density constructs. The translational aspects of these high density 
collagen materials was examined through the ultrastructure and bulk property changes 
that may be present through lyophilization and rehydration, as well as comparison against 
a gold standard market crosslinked microfibrillar collagen sponge. 
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CHAPTER 1. INTRODUCTION 
1.1 Introduction 
In vivo, cells reside within a tissue specific extracellular matrix (ECM), made up of 
a mixture of proteins, primarily Type I collagen. In vivo, collagen exhibits ordering over 
several length scales, including molecular (10-9 m), fibrillar (10-6 m), suprafibrillar (10-3 
m), and tissue/organ (10-1 m). The chemical and physical properties of this matrix guide 
cellular proliferation, migration, and differentiation1. Because of this, tissue engineering 
as a field seeks to recapitulate the design features of the natural ECM. Because Type I 
collagen makes up around 90% of the ECM, and is highly conserved across tissues and 
species, it is a logical choice for a tissue engineering material2, 3 However, to date, there 
has been a lack of a tunable collagen material with physiologically relevant properties 
and signaling capabilities, limiting collagen’s use in both research and clinical settings.  
Soluble monomeric collagens, atelocollagen and telocollagen, are commonly used 
in the research setting, and are characterized by the absence of the natural intermolecular 
crosslinks found in in vivo collagen4. This protein structure results in the collagen 
molecules, upon polymerization, self-organizing into long, randomly oriented fibrils5. 
This microstructure is characterized by its low mechanical integrity and rapid proteolytic 
degradation6. Monomeric collagen formulations have historically been limited by 
 
2 
solubility to low collagen fibril densities (<10 mg/mL), further limiting their mechanical 
integrity, tunability, and physiological relevance7.  
Because of the inherent mechanical weakness present in monomeric collagen 
formulations, several techniques have been developed to increase the collagen density 
and/or mechanical integrity, and are discussed in detail in Chapter 2. Crosslinking of 
collagen attempts to increase the mechanical integrity and resistance to proteolytic 
degradation through physical means, such as dehydrothermal treatment, or chemical 
means, such as nonspecific glutaraldehyde crosslinking. These techniques increase the 
mechanical integrity of the collagen material, but have the drawbacks of destruction of 
the microstructure and blocking of the inherent biological signaling capabilities of the 
collagen. Increasing the collagen density is typically accomplished through centrifugation 
or microinjection with continuous evaporation8, 9. These methods are relatively time 
consuming, and, although they allow for cellular migration across them, they typically 
are not amenable to cell encapsulation or infiltration10. More recently, removal of the 
fluid phase of polymerized telocollagen has been shown to greatly increase the 
mechanical integrity and fibril density of the matrix, but the process requires the removal 
of nearly the entire fluid phase of the matrix, and resulting materials are very thin (<100 
um thick) and brittle11, 12.  
 In order to overcome the issues with monomeric collagens, decellularized tissues 
or fibrillary collagen sponges may be used, and are discussed in Chapter 3. 
Decellularized tissues contain the assortment of proteins found in the natural extracellular 
matrix outside of collagen, but are subject to the inherent variability of their source 
tissues3, 13. Fibrillar collagen sponges are created through lyophilization of slurries of 
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insoluble collagen particulate, and are characterized by their amorphous microstructure of 
densely packed fibrils separated by large pores hundreds of microns across14.  These 
sponges are often exogenously crosslinked to create the collagen hemostats and drug 
carriers current on the market for clinical use15.  
To date there remains an inability to create high-density fibril materials that 
recreate hierarchical assembly of collagen found in mature tissues and tunable cell-
instructive capacity. This research works to overcome this technology gap using a 
hierarchical design strategy focused on molecular level building blocks specified based 
on intermolecular crosslink composition and polymerization capacity. To this end, the 
Voytik-Harbin lab has developed a method to extract and purify a new collagen building 
block, termed collagen oligomer, which represents a new soluble subdomain that falls 
between molecular and fibrillar size scales5, 16.  Oligomers represent aggregates of 
tropocollagen molecules (e.g., trimer) that retain their natural intermolecular crosslink17. 
When polymerized, collagen oligomers exhibit suprafibrillar assembly forming 
interconnected fibril network and demonstrating mechanical integrity far exceeding that 
of conventional monomer collagen formulations6. Previous work has documented that 
modulation of polymerization parameters including total collagen concentration and 
oligomer to monomer ratio can be used as an effective means to control fibril level 
properties, including microstructure, mechanical properties (e.g. stiffness), and 
proteolytic degradation, which are all known to guide cell fate18-20. However, oligomer 
collagen solutions are still limited to 10 mg/mL by the same solubility constraints that 
affect monomer collagen solutions, limiting their potential to create high fibril-density 
collagen matrices. To overcome this limitation, a confined compression approach was 
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used in this work to forcibly remove a portion of the interstitial fluid low-density 
oligomer matrices, effectively creating high collagen-fibril density materials with tunable 
material properties. 
The specific aims of this research were as follows: 
1. Develop and validate the utility of  confined compression as a scalable 
method for creating tunable high-density collagen-fibril materials and 
engineered tissue constructs; 
2. Define how lyophilization and rehydration effects the multi-scale structure, 
mechanical properties, and proteolytic degradation of high-density 
collagen-fibril materials; and 
3. Compare ultrastructure, mechanical properties, and proteolytic 
degradation of high-density collagen-fibril materials to the commercial 
collagen sponge Helistat 
Chapter 2 of this thesis addresses Specific Aim 1, while efforts related to Specific 
Aim 2 and 3 are descried in Chapter 3. Finally, overall conclusions of the work as well as 
opportunities for future studies are addressed in Chapter 4. 
Results from this work are important because they support the rational, translational, 
and scalable design of a broad range of collagen-based materials and cell-encapsulated 
tissue constructs with tissue-like fibril densities, suprafibrillar organizations, and 




CHAPTER 2.  ACELLULAR AND CELLULAR HIGH-DENSITY, COLLAGEN-
FIBRIL CONSTRUCTS WITH SUPRAFIBRILLAR ORGANIZATION 
2.1 Background 
In vivo, connective tissue cells reside within a tissue-specific extracellular matrix 
(ECM) which primarily represents a highly organized network of densely packed fibrous 
proteins, primarily type I collagen fibrils. It is well established that the suprafibrillar 
organization and architecture of the collagen contributes to the diversity of structural and 
functional properties displayed by the various tissues of the body1.  However, more 
recently, the microstructure, mechanical properties (e.g., stiffness), and proteolytic 
degradation properties of this fibril network have been recognized as powerful 
morphogens along with the more widely studied soluble factor and cell-cell signaling21.  
Here, type I collagen fibrils instruct fundamental cellular behaviors (e.g., proliferation, 
differentiation, migration, and matrix remodeling) associated with tissue development, 
maintenance, and repair through their inherent molecular signaling domains, including 
those involved in cell adhesion, growth factor binding, and collagen proteolytic 
degradation, as well as structural constraints22. As such, it is not surprising that a major 
goal of tissue engineering and regenerative medicine is the functional design of 




As the major structural protein of tissues, type I collagen demonstrates not only 
hierarchical, multi-scale organization but also the capacity to self-assemble into fibrous 
tissues in vivo.  As shown in Figure 1, the organizational levels of collagenous tissues 
span various size scales including molecular (10-9 m), fibrillar (10-6 m), suprafibrillar (10-3 
m), and tissue/organ (10-1 m), with tropocollagen (also known as telocollagen) 
representing the fundamental collagen polymer building block.  Tropocollagen molecules, 
which comprise a central triple helical region flanked by short non-helical telopeptide 
domains, participate in a nucleation and growth mechanism to yield microfibrils which in 
turn associate laterally and axially to yield fibrils.  Proper molecular alignment is driven 
by hydrophobic and electrostatic interactions23, 24 with additional adjustments likely 
provided by enzyme-mediated molecular crosslinking which further stabilize the 
molecular and fibril assemblies25, 26. Although extensive in-vitro study has provided a 
detailed mechanistic understanding of the molecular assembly of individual collagen 
fibrils (termed fibrillogenesis or fibrillar assembly)24, much less is known regarding 
processes associated with suprafibrillar assembly and higher-order organization25.  This 
knowledge gap has hindered the rational design and development of collagen-fibril 
materials and tissue constructs with complex hierarchical architectures and biophysical 




fibrils17.  Therefore, even at high densities (10-20 mg/ml), these matrices are associated 
with poor shape definition, low mechanical integrity, poor handling, cell-induced 
contraction, and rapid proteolytic degradation6, 30-32.  
More recently, methods have been described for creating high-density collagen-
fibril materials from soluble collagen formulations that better approximate the structural 
hierarchy and mechanical properties of mature tissues, as seen in Table 1. These methods, 
which include reverse dialysis, ultracentrifugation, and evaporation, involve generating 
high concentrations of acid-soluble collagen monomers (>20 mg/ml) followed by 
neutralization to induce fibrillogenesis.  The majority of these approaches were inspired 
by current theories and evidence that collagen suprafibrillar  organization often mimic 
geometries described in liquid crystalline states5. For example, reverse dialysis of low 
concentration monomer solutions against poly(ethylene glycol) (PEG)8, 9, 27 has been used 
alone or in conjunction with continuous microchamber injection to yield high-density 
matrices that are homogenous (250 mg/ml) or display gradients (50-500 mg/ml)33 . A 
similar approach involving microinjection and evaporation followed by fibrillogenesis 
yielded concentration and ultrastructure gradients extending from 5-1000 mg/ml10. 
Unfortunately, these approaches require long production times (weeks to months) and are 
not amenable to cell encapsulation. Furthermore, while these high density materials 
support cell adhesion and growth along the surface, migration or infiltration into the 







Table 1 – Densification Strategies 











up to 70kPa elastic 
modulus 
yes 





weeks to months 
ammonia vapor 
thin matrices up to 
1000 mg/mL 
not shown no 
Mosser, 2006. Besseau, 
1995. 
reverse dialysis 






375 mg/mL not shown No 










dense thin sheets 
(~98% weight 
loss) 
up to 4 Mpa elastic 
modulus 





Neel, 2006. Bitar, 2007. 
Cheema, 2013. Mudera, 
2007. Brown, 2005. 
Hadjipanayi, 2009. 
 
An alternative 2-step method for achieving high-density collagen-fibril materials 
that is more amenable to cell encapsulation involves polymerization of low concentration 
monomer solutions followed by unconfined plastic compression and/or capillary fluid 
flow into blotting paper layers to reduce the interstitial fluid content 11. Here, low-loads 
(50-60 g or 1.1 kPa) are applied to the top of a collagen matrix (~ 2-5 mg/ml) to achieve 
fluid reduction (~85-99.8% compressive strain) through a supporting nylon mesh11, 36.  
The resulting sheets, which are 20 to 100 um in thickness, are fragile, requiring spiraling 
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to facilitate handling and further testing.  They display tensile strength and modulus 
values of 0.6 ± 0.11 MPa and 1.5 ± 0.36 MPa, respectively, and support 85% viability of 
encapsulated cells12.    Additional compression of spiraled constructs improves 
mechanical integrity but reduces cellular viability12, 36. 
In the present work, we demonstrate the benefit of combining suprafibrillar 
assembly with fibril-matrix densification strategies for creating broadly customizable, 
scalable, high-density collagen-fibril constructs in the presence and absence of cells. The 
first step involves the use of standardized collagen oligomers to prepare low 
concentration matrices (<10 mg/ml) with specified and highly reproducible 
microstructure and physical properties (intermolecular crosslink content, fibril density, 
interfibril branches, and proteolytic degradability). Oligomers, which represent soluble 
aggregates of tropocollagen molecules (e.g., trimers) that retain their natural 
intermolecular crosslinks, exhibit not only fibrillar but also suprafibrillar assembly. Next, 
confined, rather than unconfined, compression is applied to controllably reduce fluid 
content and increase the fibril density. Interestingly, we show that this approach is not 
applicable to collagen-fibril matrices prepared from conventional collagen monomer 
preparations, telocollagen and atelocollagen.  This is largely owing to their limited self-
assembly capacity and inability to yield fibril microstructures that can sustain or support 
the associated compressive and fluid shear forces. Results from this work are important 
because they support the rational and scalable design of a broad range of collagen-based 
materials and cell-encapsulated tissue constructs with tissue-like fibril densities, 
suprafibrillar organizations, and functional properties for tissue engineering and 
regenerative medicine applications. 
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2.2 Materials and Methods 
2.2.1 High-Density Collagen-Fibril Construct Preparation 
Type I collagen oligomers were acid solubilized from dermis of market weight pigs 
and lyophilized for storage as described previously18. Prior to use, the lyophilized 
collagen was dissolved in 0.01 N hydrochloric acid (HCl) and rendered aseptic by 
chloroform exposure at 4°C. Collagen concentration was determined using a Sirius Red 
(Direct Red 80) assay37.  The oligomer formulation was standardized based upon purity 
as well as polymerization capacity according to ASTM standard F3089-1438.  Here, 
polymerization capacity is defined by matrix shear storage modulus (G’) as a function of 
collagen concentration of the polymerization reaction. Commercial acid-soluble rat tail 
collagen (telocollagen) and pepsin-solubilized bovine dermis collagen (atelocollagen) 
were obtained from Corning (Corning, NY) and Advanced BioMatrix (Carlsbad, CA), 
respectively.  All collagen solutions were diluted with 0.01 N HCl to achieve desired 
concentrations and neutralized with 10X phosphate buffered saline (PBS) and 0.1N 
sodium hydroxide (NaOH) to achieve pH 7.417. Neutralized solutions were kept on ice 
prior to inducing polymerization by warming to 37°C.  
 All acellular oligomer collagen-fibril constructs were prepared with an initial 
starting collagen concentration of 3.5 mg/ml in 2 cm X 4 cm block molds.  After 
polymerization and incubation at 37°C for 1 hour (tensile testing only) or 18 hours (used 
for all tests), each construct was compressed within the block mold to a final thickness of 
2 mm (1.6 mL volume) with a porous polyethylene platen (50 µm pore size; Scientific 
Commodities, Inc., Lake Havasu City, AZ) at a rate of 6 mm/min. Final construct 
 
12 
collagen concentration was controlled by varying the initial polymerized collagen volume.  
More specifically, starting volumes of 1.6 mL, 5.6 mL, and 11.2 mL of 3.5 mg/mL 
collagen (initial concentration) were differentially compressed to yield 3.5 mg/ml (no 
compression), 12.25 mg/ml (71% strain), and 24.5 mg/mL (86% strain) constructs, 
respectively. Assuming all collagen polymerized, these constructs represented collagen 
wet weights (w/w) of 0.6%, 2.1% and 4.2%, respectively, as measured from the masses 
of hydrated and lyophilized constructs (data not shown).  Commercial telocollagen and 
atelocollagen were polymerized to a collagen concentration of 3.5 mg/mL and allowed to 
polymerize at 37C for 18 hours before being subjected to compression identical to that 
detailed above to 86% strain.  
2.2.2 Collagen Fibril Micro- and Ultra-Structure Analysis 
The fibril microstructure and ultrastructure of the collagen constructs was 
visualized using confocal reflection microscopy39 and cryo-SEM40, respectively. 
Confocal reflection microscopy was performed using an Olympus Fluoview FV-1000 
confocal system adapted to an Olympus IX81 invested microscope with a 60X 
UPlanSApo water immersion objective (Olympus, Tokyo, Japan). Cryo-SEM images of 
samples were obtained using an FEI NOVA nanoSEM 200 (FEI, Hillsboro, OR).   
Samples were quick frozen by submersion into liquid nitrogen cooled to its triple point,  
transferred to a CT1000 coldstage attachment (Oxford Instruments North America, Inc., 
Concord, MA), and sublimated under vacuum before sputter coating and imaging. 
Collagen constructs used for AFM analysis of D-periodic banding were 
extensively rinsed with water and then air dried.  Samples were imaged in air using a 
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Bruker BioScope Catalyst AFM (Bruker Corporation, Santa Barbara, CA ) as described 
previously41. In brief, images were acquired in a peak force tapping mode using 
ScanAsyst Fluid+ probes (silicon tip, silicon nitride cantilever, nominal tip radius 2 nm 
and nominal stiffness of 0.7 N/m). From each sample (n=4 per group), 15-20 fibrils at 
each of 2 locations were imaged and analyzed (~150 total fibrils per group).  Two-
dimensional fast fourier transforms were performed and the primary peak from the 2D 
power spectrum was analyzed to determine the value of the D-periodic spacing for 
individual fibrils.  
2.2.3 Mechanical Testing 
Tensile testing was performed on dog-bone shaped collagen constructs with a 
gauge length, width, and thickness of 26 mm, 4 mm, and 2 mm, respectively. All samples 
were tested in uniaxial tension to failure at a strain rate of 10 mm/second using a servo 
electric materials testing system (Testresources, Shakopee, MN). Stress measurements 
were obtained using a 10 lb load cell (LPM 512, Cooper Instruments, Warrenton, VA) at 
a sampling rate of 100 Hz. Engineering tensile modulus (ET) was calculated from the 
linear region of the stress strain curve. Ultimate stress (?U) represented peak stress 
experienced by the sample, and failure strain (?f) was the strain at which constructs 
experienced total failure. (n=7).  
2.2.4 Proteolytic Degradability 
Proteolytic degradation was measured by measuring compressive modulus and 
hydroxyproline content of constructs before and after 2-hour exposure to bacterial 
collagenase type IV (31.2 U/mL; Worthington, Lakewood, NJ). Collagen constructs 
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prepared at 3.5, 12.25, and 24.5 mg/mL were punched to form cylinders with diameter 
and thickness of 1 cm and 2 mm, respectively.  Constructs were tested in unconfined 
compression at 17%/second to 75% strain using a servo electric materials testing system 
(Testresources, Shakopee, MN) adapted with a 10 lb load cell (LPM 512, Cooper 
Instruments, Warrenton, VA).  Compressive modulus was calculated as the slope of the 
linear region of the stress-strain curve.  Compression tests were performed on seven 
independent constructs per group (n=7). Control and collagenase-treated constructs were 
then subjected to a spectrophotometric-based hydroxyproline assay (Sigma Aldrich) to 
determine collagen content.  
2.2.5 Cellularized High-Density Tissue Construct Preparation 
Low passage human adipose-derived stem cells (hASC) were obtained from Zen-
Bio (Research Triangle Park, NC). Cells were cultured in 50/50 mixture of DMEM/F12 
medium (Life Technologies, Carlsbad, CA) with 10% FBS, 100 U/mL Penicillin, and 100 
U/mL Streptomyosin (Invitrogen, Grand Island, NY).  hASC were grown and maintained 
in a humidified environment of 5% carbon dioxide in air at 37°C.  Cells were kept below 
80% confluence and used in experiments at passage 6 to 9.  
To create cellularized, high-density, collagen-fibril constructs, hASC were added 
to neutralized oligomer solutions (3.5 mg/mL) and polymerized for 15 minutes at 37°C 
(Figure 7). Tissue constructs representing different volumes, specifically 50 µL, 175 µL, 
or 350 µL, were created in glass-bottom 96-well plate (Corning, Corning, NY). 
Constructs were densified to 1.5 mm final thickness (50 µL volume) at 6 mm/min using a 
porous polyethylene platen (Scientific Commodities, Inc.). Final hASC density within 
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constructs was 5 x 105 cells/mL. Immediately following densification, 200 µL of medium 
was added to each well and tissue constructs were maintained in a humidified 
environment at 37oC and 5% CO2 in air with medium changes every 24 hours.  
Cell viability was evaluated at 48 hours by staining with Celltracker (5-
chloromethylfluorescein diacetate; Molecular Probes, Eugene, OR) and propidium iodide 
(Sigma-Aldrich). Confocal images stacks (50-µm thick) were collected and used for 
live/dead analyses (n=6). Cell morphology and cell-matrix interactions were assessed by 
staining constructs with phalloidin (Molecular Probes, Eugene, OR) and Draq5 (Biostatus 
Limited, Leicestershire, United Kingdom) for visualization of F-actin and the nucleus, 
respectively.   
2.2.6 Statistical Analysis 
Statistical analysis was performed in Minitab statistical software. One-way 
ANOVA was applied across collagen concentrations (3.5, 12.25, and 14.5 mg/mL) with a 
Tukey post-hoc test to determine differences in mean values. In cases where population 
variances were not equal (ultimate stress, elastic modulus, compressive modulus), a 
Kruskal-Wallis test was performed in place of ANOVA with post-hoc 2-sample T-tests 
assuming non-equal population variances. Mean D-periodic spacing values were 
compared using an ANOVA and a post-hoc Holm-Sidak test. To examine differences in 
the distribution of fibril D-periodic spacing values, the Cumulative Distribution Function 
(CDF) of each group was computed and statistically compared using a Kolmogorov-
Smirnov (KS) test. A critical global p-value of 0.05 was used. 
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2.3 Results and Discussion 
2.3.1 Type I Collagen Oligomers Demonstrate in-vitro Fibrillar and Suprafibrillar 
Assembly and Support Confined Compression 
Recently, we described the isolation and purification of type I collagen oligomers, 
which appear to represent a new soluble subdomain that falls between molecular and 
fibrillar size scales16, 17.  As shown in Figure 1B, oligomers represent tissue-derived 
aggregates of tropocollagen molecules (e.g., trimer) that retain their natural 
intermolecular crosslink.  Unlike conventional collagen monomers, oligomers exhibit 
rapid fibril and suprafibrillar self-assembly yielding highly interconnected collagen-fibril 
matrices with dramatically improved mechanical integrity, handling, and reduced 
proteolytic degradation6. As a result when polymerized at the same final collagen 
concentration, oligomer matrices have dramatically improved shape retaining capacity, 
mechanical integrity, and resistance to cell-induced contraction compared to their 
monomer counterparts5. More specifically, the stiffness range prepared for oligomer 
matrices prepared at 0.5-4 mg/ml was 40-1500Pa, while that for telocollagen and 
atelocollagen preparations was 2-300Pa and 2-50Pa, respectively6.   
Here, high resolution AFM images (Figure 2) were used to confirm that low-
density oligomer matrices represent highly interconnected fibril networks with D-
periodic spacing resembling that found in vivo.  As shown in Figure 2A-C, component 
fibrils within oligomer and telocollagen but not atelocollagen matrices displayed highly 
regular and prominent D-periodic spacing patterns. These results confirm previous 






can be used to drastically improve mechanical properties and proteolytic degradability of 
collagen-fibril materials in absence of exogenous crosslinking and other processing. 
Since stress-strain behavior of reconstituted collagen matrices has been shown to 
be dependent upon polymerization time17, oligomer matrices were polymerized for 1 hour 
or 18 hours, prior to densification and follow-up tensile testing. Despite the 
polymerization time, confined compression resulted in high-density collagen-fibril 
constructs with increased ultimate strength and elastic modulus.  While polymerization 
time did not significantly affect mean mechanical property values, constructs 
polymerized for 18 hour showed improved reproducibility as evidenced by reduced 
standard deviation.  As such an 18-hour polymerization time was adopted as a preferred 
mode.  
Comparison of collagen-fibril constructs prepared at 3.5, 12.25, and 24.5 mg/ml 
showed that both ultimate stress and elastic modulus increased in a nearly linear fashion 
with collagen content (Figure 5).  Ultimate stress values showed statistically significant 
increases from 65.7 kPa to 120.8 kPa to 212.9 kPa for 3.5, 12.25, and 24.5 mg/mL 
samples, respectively (p<0.01).  Likewise, elastic modulus increased in a statistically 
significant fashion from 0.40MPa to 0.88MPa to 1.26 MPa over the range tested (p<0.05; 
Figure 5). All samples, regardless of densification, failed near 0.28 mm/mm strain (Table 
2).  The significant contribution of higher-order suprafibrillar assembly to the mechanical 
properties of densified collagen-fibril constructs is evident upon comparison of results 
obtained in the present study with oligomer collagen with those obtained with previously 
with conventional monomer formulations.  More specifically, telocollagen required 




Densification of collagen-fibril constructs was also found to modulate in-vitro 
proteolytic degradation properties as measured using collagenase from Clostridium 
histolyticum.  While the specificity of mammalian collagenase is more limited compared 
to bacterial collagenase, good empirical correlation between the extent of in-vitro 
degradation by bacterial collagenase and in-vivo degradation by mammalian collagenase 
has been documented47. Qualitative and quantitative assessment of collagenase 
degradation (Figure 6) showed that the extent of densification affected not only the 
degradation rate but also to some extent the degradation mechanism (surface versus bulk).  
Following 2-hour exposure, the 3.5 mg/mL constructed was nearly entirely 
degraded, while the 12.25 mg/ml and 24.5 mg/ml constructs showed markedly higher 
collagenase resistance.  Interestingly, 12.25 mg/mL constructs appeared to develop small 
degraded regions throughout the surface area of the construct, consistent with bulk 
degradation.  In contrast, degradation of the 24.5 mg/mL construct appeared more 
concentrated to the edges indicative of more limited diffusivity and surface degradation. 
Proteolytic degradation of the constructs also was defined and compared quantitatively 
based on the change in compressive modulus before and after 2-hr collagenase treatment 
(Figure 6B).  Here, as shown in Figure 6C, collagenase-treated 3.5 mg/ml constructs 
showed a dramatic reduction in compressive modulus to 6.7% of untreated controls.  In 
contrast, 12.25 mg/ml and 24.5 mg/ml samples showed significantly reduced levels of 
collagenase degradation with compressive modulus values of 47% and 71% of untreated 
controls.  The collagenase induced changes in mechanical performance correlated well 




tissue engineering applications48, 49. Cell viability, morphology, and F-actin (phalloidin) 
distribution then were assessed after 48 hours of culture. Control 3.5 mg/mL constructs 
showed  94.29 ± 2.42% cell viability, while viability within densified 12.25 mg/ml and 
24.5 mg/mL constructs was 89.57 ± 2.43 and 88.96 ±2.48%, respectively (Table 3). 
Although cell viability remained high in all cases, values for densified constructs were 
statistically lower than the control (p<0.05), but not statistically different from each other 
(p=0.65).  Collectively, these results document that the compressive loads, fluid shear 
forces, and high fibril densities do not compromise cell health.  
Visualizing F-actin organization (phalloidin) within hASCs encapsulated within 
various high-density collagen-fibril constructs provided important insights regarding the 
cell-collagen interactions and associated mechanobiology signaling.  The actin 
cytoskeleton is well recognized for its role in cell morphology as well as establishing 
physical linkage between the cell interior and collagen fibrils of the extracellular matrix 
through focal adhesions50.  Here, encapsulated hASCs were able to sense and respond to 
the different mechanobiology cues provided by the 3 different collagen constructs as 
demonstrated by their markedly different morphologies and F-actin distributions (Figure 
7C-E). In the control 3.5 mg/mL constructs, cells were spindle-shaped and elongated with 
prominent actin stress fibers along their long axis. Cells encapsulated within 12.25 mg/ml 
and 24.5 mg/ml constructs responded to the progressive increase in fibril density and 
associated matrix stiffness by taking on more stellate and polygonal morphologies, 
respectively. Furthermore, actin stress fibers became less prominent with the adoption of 
a more uniformly-distributed, punctate F-actin staining pattern. These morphology and 





The development of functional tissue constructs for research and medical 
applications requires an in-depth understanding of how cells interact and respond to the 
surrounding extracellular matrix. Since collagen exists in vivo as fibers and is the major 
component of connective tissue, oligomeric collagen-fibril matrices provide a highly 
physiologically relevant system. A key finding of this work is the benefit of oligomers 
and their associated suprafibrillar assembly capacity for creating acellular or cellular 
collagen-fibril constructs with tissue-like appearance, handling, and performance. 
Densification of oligomer collagen matrices irreversibly removed a portion (71-86%) of 
the fluid from the material, reproducibly creating novel materials with the collagen 
concentration and strength of soft connective tissues. The material is capable of being 
made without the use of any exogenous crosslinking chemicals or matrix destroying 
processes, retaining the collagen’s in vivo branched fibril microstructure. The 
densification process was shown to be amenable to creating high density cellularized 
tissue constructs. This material, with its hierarchical tuning capability of material 
properties, shows large promise for tissue engineering applications and basic science 
studies, such as three dimensional cell culture.
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CHAPTER 3.  TRANSLATIONAL DESIGN ASPECTS OF HIGH-DENSITY 
COLLAGEN-FIBRIL CONSTRUCTS 
3.1 Introduction 
Collagen is the major structural element of connective tissues and the prominent 
component of the extracellular matrix.  Its suprafibrillar assembly and hierarchical 
organization varies from tissue to tissue bringing diversity in form and function1.  In 
addition to conferring structure and mechanical properties to the body’s tissues and 
organs, this natural polymer has been more recently recognized for its critical role in 
cellular signaling associated with tissue development, maintenance, and repair53.  Both 
in-vitro and in-vivo studies have shown that the collagen fibril microstructure and 
stiffness of the cell microenvironment  provide important guidance cues that regulate not 
only fundamental behavior of differentiated cells but also differentiation and 
morphogenesis of multipotent stem cells54.  Instrumental to this mechanobiology 
signaling are molecular signaling domain for cell adhesion, proteolytic degradation, and 
growth factor binding inherent to the tropocollagen molecule, which represents the 
fundamental collagen building block55.  
The clinical applications of collagen have been limited by the non-in vivo like 
state of collagen products. To date, collagen-based material and tissue design for both 
research and medical applications has relied on a limited number of collagen 
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formulations known to vary in purity and biomechanical and biochemical signaling 
capabilities. A variety of collagen materials have seen extensive clinical use as 
biodegradable hemostatic agents, bulking agents for plastic surgery, wound coverings and, 
more recently, as biodegradable drug delivery vehicles3. Formulations used to date 
include purified collagen gels, decellularized matrices, and fibrillary collagen sponges. 
These materials create a more biological interface between the body and the wound, 
aiding the healing process. Due to the biodegradability of the collagen, which is lessened 
by crosslinking through physical or chemical means in some forms, the materials can be 
left in after surgery and slowly degraded and removed from the body with minimal 
adverse reactions15. However, the clinical uses of collagen to date do not readily take 
advantage of the biomechanical and biochemical signaling capabilities of the collagen.  
Collagen has seen extensive use, particularly in research applications, in the form 
of purified collagen solutions which can form gels. This form of collagen has the clinical 
advantage of being injectable, and forming a gel within the body. However, the dissolved 
collagen solutions are limited in concentration by solubility, and are traditionally 
monomeric collagen formulations5. Monomeric collagen formulations lack the natural 
intermolecular crosslinks found in in vivo collagen, severely limiting the polymerization 
capacity of the solution as well as the mechanical integrity of the polymerized gel18. 
Films of collagen have been used in combination with other materials or cells as a 
treatment for burns, due to their impermeability to bacteria and low antigenicity14, 
56
.Soluble, polymerizable monomeric collagen has been used in combination with cells in 
an FDA approved skin substitute under the trade name of Apligraf. Apligraf consists of a 
collagen matrix which has been contracted by human fibroblasts. This method of action, 
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cellular contraction, to create a higher collagen fibril density matrix functions due to the 
inherent weakness found in these monomeric collagens, which allows the force of the 
cells to tightly contract the matrix. In addition, the inclusion allogenic cells can illicit an 
immunogenic response from the recipient. 
In order to overcome the low mechanical integrity of collagen formulations, 
decellularized tissues have been used. These materials consist of the extracellular 
matrices of natural tissues, such as small intestine or urinary bladder, with the cells 
removed, retaining the mixture of proteins naturally found in the donor site13. Other 
tissue sources used include heart valves, skin, and skeletal muscle3. However, these 
materials are subject to more inherent variability, as the individual differences between 
donor sites are not removed. As such, the microstructure, protein makeup, and 
mechanical properties are all subject to variances in the humans and animals they are 
obtained from57. These products can also be exogenously crosslinked to gain higher 
mechanical integrity, but at the cost of the natural biochemical signaling capabilities of 
that tissue.  
Insoluble collagens (also referred to as fibrillar collagens) that don’t polymerize 
are routinely fashioned into high-density, porous collagen sponges through lyophilization 
of collagen slurries. To create these products, tissue sources high in collagen content, 
such as tendon, are milled into particulate, washed to remove excess proteins such elastin, 
crosslinked, frozen, and lyophilized. Overall, these materials have amorphous (non-
fibrillar) microstructures and are often further subjected to exogenous chemical or 
physical crosslinking to improve mechanical properties and decrease proteolytic 
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degradability. The collagen causes platelets to clot upon contact, allowing control over 
blood loss during surgery58. 
The collagen sponges have also seen recent clinical use as drug delivery vehicles 
for a number of drugs, including gentamicin and rh-BMP215. In these forms, the 
lyophilized collagen sponge is soaked in solution containing the drug prior to 
implantation in the body. The sponge is then degraded by the body, allowing some 
extended release of drug into the body, and the collagen sponge is degraded and removed 
from the body over time.  
 In short, the currently available collagen formulations lack the in vivo 
microstructure, resistance to degradation, and mechanical integrity of natural collagen, 
and in order to regain some of the lost mechanical integrity, as in exogenous crosslinking, 
the natural microstructure is further damaged. This process leaves the collagen materials 
with properties that are far exceeded by the natural collagen, and are unfit to guide 
cellular fate and behavior in a clinically relevant fashion. This lack of a physiologically 
relevant form of processed collagen must be overcome to take clinical advantage of the 
collagen’s biochemical and biophysical signaling capabilities for tissue engineering and 
regenerative medicine applications.  
Recently, we described the isolation and purification of type I collagen oligomers, 
which appear to represent a new soluble subdomain that falls between molecular and 
fibrillar size scales6.  Oligomers represent aggregates of tropocollagen molecules (e.g., 
trimer) that retain their natural intermolecular crosslink.  More specifically, 
characterization studies performed to date suggest that oligomers purified from porcine 
dermis represent a prong-shaped molecule in which three molecules are covalently 
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connected at ?1-Hyl 87, ?2-His 92, and ?1-Lysald 16c amino acid residues by the 
histidinohydroxylysinonorleucine crosslink18, 59.  Unlike conventional collagen monomers, 
oligomers exhibit rapid fibril and suprafibrillar self-assembly yielding highly 
interconnected collagen-fibril matrices with dramatically improved mechanical integrity, 
handling, and reduced proteolytic degradation. More recently, low-density matrices were 
found to exhibit plastic deformation when subjected to confined compression, creating 
high density (>10 mg/mL) collagen-fibril materials that appear and handle like soft 
connective tissues and support cell encapsulation. More specifically, the plastic 
deformation created collagen fibril materials with tunable elastic moduli ranging from 
400 kPa to 1.3 MPa, with 90% cell viability exhibiting different encapsulated hASC 
morphology at 48 hours post-densification. The process was also found to be capable of 
creating gradients in collagen fibril density and alignment. 
Here we extend this work by evaluation lyophilization as a means to promote 
stability, preserve biological function, and facilitate long-term storage of high-density 
collagen-fibril materials. Lyophilization represents the current industry standard for 
prolonging the shelf life of collagen and other biologically based materials60. Studies 
involved high density collagen-fibril materials, representing 24.5 mg/mL oligomeric 
collagen. Multi-scale structural properties, mechanical behavior, and proteolytic 
degradation are compared before and after lyophilization and rehydration. In addition, 
this high density collagen-fibril material is compared to Helistat, a commercial collagen 
sponge used for hemostasis and drug delivery15, 61. Results document how the 
suprafibrillar assembly of collagen oligomers dramatically improves the mechanical 
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integrity of biosynthetic collagen biomaterials while maintaining a highly porous 
collagen-fibril microenvironment with tunable mechanobiology signaling.   
 
3.2 Materials and Methods 
3.2.1 Preparation of High-Density Oligomer Collagen-Fibril Materials 
Type I collagen oligomers were acid solubilized from dermis of market weight 
pigs and lyophilized for storage as described previously6. Prior to use, lyophilized 
collagen was dissolved in 0.01 N hydrochloric acid (HCl) and rendered aseptic by 
chloroform exposure at 4°C. Collagen concentration was determined using a Sirius Red 
(Direct Red 80) assay 30. The oligomer formulation was standardized based upon purity 
as well as polymerization capacity according to ASTM standard F3089-14 38.  Here, 
polymerization capacity is defined by matrix shear storage modulus (G’) as a function of 
collagen concentration of the polymerization reaction. Oligomer solutions were diluted 
with 0.01 N HCl to achieve desired concentrations and neutralized with 10X phosphate 
buffered saline (PBS) and 0.1N sodium hydroxide (NaOH) to achieve pH 7.4 18. 
Neutralized solutions were kept on ice prior to inducing polymerization by warming to 
37oC.  
 Oligomer collagen-fibril matrices were prepared with an initial starting collagen 
concentration of 3.5 mg/ml in 2 cm X 4 cm block molds. After polymerization and 
incubation at 37°C for 18 hours, each matrix was compressed within the block mold to a 
final thickness of 2 mm (1.6 mL volume) with a porous polyethylene platen (50 µm pore 
size; Scientific Commodities, Inc., Lake Havasu City, AZ) at a rate of 6 mm/min. Final 
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collagen concentration was controlled by varying the initial polymerized collagen volume.  
More specifically, a starting volume of 11.2 mL of 3.5 mg/mL collagen (initial 
concentration) were compressed to yield 24.5 mg/mL (86% strain) constructs. 
Commercial Collagen sponges (Helistat) were purchased from Miltex (York, PA). 
3.2.2 Collagen Biomaterial Micro- and Ultrastructure Analysis 
The fibril micro- and ultra-structure of the commercial Helistat collagen sponge 
and oligomer collagen-fibril materials were visualized using SEM as well as cryo-SEM. 
SEM and Cryo-SEM images of samples were obtained using an FEI NOVA nanoSEM 
200 (FEI, Hillsboro, OR).  Lyophilized samples were mounted and sputter coated under 
vacuum prior to imaging. Rehydrated samples were quick frozen by submersion into 
liquid nitrogen cooled to its triple point,  transferred to a CT1000 coldstage attachment 
(Oxford Instruments North America, Inc., Concord, MA), and sublimated under vacuum 
before sputter coating and imaging. 
3.2.3 Mechanical Testing 
Tensile testing was performed on dog-bone shaped rehydrated collagen constructs 
with a gauge length, width, and thickness of 26 mm, 4 mm, and 2 mm, respectively. All 
samples were tested in uniaxial tension to failure at a strain rate of 10 mm/second using a 
servo electric materials testing system (Testresources, Shakopee, MN). Stress 
measurements were obtained using a 10 lb load cell (LPM 512, Cooper Instruments, 
Warrenton, VA) at a sampling rate of 100 Hz. Engineering tensile modulus (ET) was 
calculated from the linear region of the stress strain curve. Ultimate stress (?U) 
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represented peak stress experienced by the sample, and failure strain (?f) was the strain at 
which constructs experienced total failure. (n=7).  
3.2.4 Suture Retention 
Helistat collagen sponges and lyophilized high-density oligomer collagen-fibril 
matrices were hydrated and their suture retention strength quantified according to ASTM 
standard protocol STP89862.  Prolene suture (5-0) was looped through the material at a 
“bite distance” (distance between the edge of the material and the suture) of 1.5 mm [7]. 
The suture then was looped through a hook connected to a servo electric materials testing 
system (Testresources, Shakopee, MN) and tied using several square knots to prevent 
slipping. The suture was then pulled by the tensile tester at a crosshead speed of 25.4 
mm/min until failure, and the peak force was recorded in grams. Force measurements 
were obtained using a 10 lb load cell (LPM 512, Cooper Instruments, Warrenton, VA) at 
a sampling rate of 100 Hz. (n=7). 
3.2.5  Proteolytic Degradability 
Proteolytic degradation was assessed by measuring compressive modulus of 
constructs before and after 2-hour exposure to bacterial collagenase type IV (31.2 U/mL; 
Worthington, Lakewood, NJ). Helistat collagen sponge and oligomer collagen-fibril 
material (24.5 mg/ml) were punched to form cylinders with diameter and thickness of 1 
cm and 2 mm, respectively.  Constructs were tested in unconfined compression at 
17%/second to 75% strain using a servo electric materials testing system (Testresources, 
Shakopee, MN) adapted with a 10 lb load cell (LPM 512, Cooper Instruments, Warrenton, 
VA).  Compressive modulus was calculated as the slope of the linear region of the stress-
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strain curve.  Compression tests were performed on seven independent constructs per 
group (n=7).  
3.2.6 Statistical Analysis 
For each measure, two-sided t-tests were performed between the high-density 
oligomer collagen-fibril matrices and the commercial collagen sponges with a critical p-
value of 0.05.  
3.3 Results and Discussion 
3.3.1 Rehydrated High-Density Oligomer Collagen-Fibril Matrices 
3.3.1.1 Ethanol Rehydration Preserves Marcrostructure and Ultrastructure 
Lyophilization is a useful tool for prolonging the shelf life of collagen or other 
biologically based materials. Lyophiliztion of decellularized urinary bladder extracellular 
matrix was found to have minimal effects on the mechanical properties over a year after 
the lyophilization occurred, whether stored in a room temperature or refrigerated 
environment63. When rehydrated using water or 1X phosphate buffered saline, the high-
density oligomer collagen-fibril matrices experienced macrostructure collapse, decreasing 
in thickness from 2 mm to approximately 0.4 mm. When first subjected to the short 
incubation in ethanol, the high-density oligomer collagen-fibril matrices retained their 
macrostucture thickness of 2 mm. This pattern was examined using graded mixtures of 
??????????????????????????????????????????????????????????????????????????????????????
mN/m64, the solution caused collapse of the high-density oligomer collagen-fibril matrix, 
????????????????????????????????????????????????????????? ???64 the structure did not 
 
36 
collapse (Figure 8). During rehydration with water only, the rehydration and collapse 
took place over a long period of time, on the order of an hour. Ethanol rehydration, in 
contrast, was complete in under one minute, and the replacement of ethanol with water 
when placed in the water bath happened over a short timescale as well, complete in under 
5 minutes. 
The differences in rehydration are likely due to the effect of the surface tension on 
the fibril microstructure of the oligomeric collagen, as limiting osmotic forces and 
surface tension are critical for optimal rehydration. Ethanol in particular has previously 
been shown to be a useful tool in the rehydration of chitosan scaffolds65. Under 
rehydration with solutions with relatively high surface tension, the fibrils are bent and 
buckled by the incoming force of the fluid, collapsing the structure. When rehydrated 
using solutions with low surface tension, such as ethanol, the force on each fibril is low 




oligomer collagen-fibril matrix was very similar to that seen in the lyophilized oligomer 
sponge, being made up of an interconnected, branched collagen fibril network.  
3.3.1.2 Mechanical Properties of Rehydrated High-Density Oligomer Collagen-Fibril 
Matrices  
The high-density oligomer collagen-fibril matrices showed an average ultimate 
tensile stress of 196.9 ± 66.0 kPa, failure strain of 0.33 ± 0.03 mm/mm, and elastic 
modulus of 1.29 ± 0.52 MPa. The ultimate stress, failure strain, and elastic modulus of 
the rehydrated high-density oligomer collagen-fibril matrix were all found to be 
statistically similar to those of the oligomeric collagen of identical preparation that had 
not undergone a lyophilization procedure. The suture retention strength of the high-
density oligomer collagen-fibril matrix was 0.54 ± 0.16 N. Data summarized in Figure 9. 
The oligomeric collagen was found to have a statistically similar suture retention strength 
to the rehydrated high-density oligomer collagen-fibril matrix, with a suture retention 
strength of 0.65 ± 0.21 N. Overall, no differences were found between the mechanical 
properties of the hydrated and rehydrated high-density oligomer collagen-fibril matrices. 
The properties of the polymerized high-density oligomer collagen-fibril matrix are orders 
of magnitude higher than the 1-30 kPa elastic modulus seen in polymerized monomeric 
collagen formulations6. In addition, the elastic modulus values are similar to those seen 






ultrastructure was shown to be made up of regions of dense compacted fibrils separated 
by large pores up to several hundred microns across.  
3.3.2.2 Mechanical Properties 
The Helistat commercial collagen sponges showed an average ultimate tensile 
stress of 47.8 ± 7.4 kPa, failure strain of 0.32 ± 0.08 mm/mm, and elastic modulus of 0.27 
± 0.03 MPa. Data shown in Figure 12. The high-density oligomer collagen-fibril matrix 
was found to have statistically significantly higher values for ultimate stress and elastic 
modulus, and a statistically similar value for failure strain. The high-density oligomer 
collagen-fibril matrix having an order of magnitude higher elastic modulus than the 
Helistat is quite noticeable considering the high-density oligomer collagen-fibril matrix 
contains no exogenous crosslinking, while the Helistat is formaldehyde crosslinked. This 
increased elastic modulus also brings the material properties of the high-density oligomer 
collagen-fibril matrix into the realm of soft tissues found in the body, implying its 
usefulness in reconstructive surgery as a tissue replacement. The suture retention strength 
of the Helistat commercial collagen sponge was 0.34 ± 0.08 N. The high-density 
oligomer collagen-fibril matrix was found to have a statistically significantly higher 
suture retention strength, although both fall short of the generally accepted 2N 
requirement for surgical use67. The elastic modulus of the Helistat is similar to the 50-200 
kPa elastic modulus reported for collagen-GAG sponges crosslinked with 
dehydrothermal treatment, UV irradiation, and/or glutaraldehyde68. Overall, the high-





those levels found in soft tissues. This is important as the mechanical properties of the 
extracellular matrix have been found to have an overwhelming effect on the cells that 
interact with it, so much so that the mechanical cues can override the signals given by 
soluble factors in vitro. Even more notable is that the high-density oligomer collagen-
fibril matrix was capable of achieving such high mechanical properties without the need 
for exogenous aldehyde crosslinking, which is known to have deleterious effects on the 
biological signaling capabilities of collagen, as well as potentially harmful cellular 
responses45. The creation of a tissue-like collagen sponge material which can be 
lyophilized and stored for long periods before use as a tissue replacement could have 
great utility as a soft tissue replacement for mastectomies, or as a tissue replacement for 
deep burn wounds or ulcers. These materials may allow for full integration into the 
patient and allow for exemplary healing. In the cases of hard tissue replacement and void 
filling, such as bone, the increased material properties will likely lead to more adequate 
bone formation due to the strength and density of the matrix giving cues to the natural 
osteoclasts and osteoblasts responsible for bone growth and repair. These claims require 
further study into the in vivo behavior of these high-density oligomer collagen-fibril 
matrices.  
The use of ethanol as a rehydrating agent allowed the collagen materials to retain 
their pre-lyophilization ultrastructure and mechanical properties. Ethanol is often used in 
the laboratory setting as a sterilization solution, and has been shown to have limited 
effects on the properties of collagen matrices68. 
Overall, the materials created for this study provide the controllable 
microstructure and repeatability of polymerizable collagen, the natural biophysical 
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signaling properties and mechanical properties of decellularized tissue, and the long term 
storage and ease of use of fibrillary collagen sponges, without the need for any 
exogenous crosslinking.  
It should be noted that the high-density oligomer collagen-fibril matrix has not 
undergone sterilization, as the Helistat has, and this has been known to have an effect on 
the mechanical properties of collagen based products. However, the effects of 
sterilization, and in particular ETO sterilization which is commonly used for collagen 
based products, have been non-substantial changes in integrity, cellular proliferation, or 
proteolytic degradation, and an increase in tensile strength.  
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CHAPTER 4.  CONCLUSION 
4.1 Conclusions 
The oligomeric collagen formulations have a distinct advantage over other 
monomeric collagen formulations because of their innate ability to self-assemble into 
branched fibril networks similar to those found in collagen in vivo. This microstructure 
shows drastic mechanical integrity improvements over monomeric collagens. The high 
mechanical integrity allows the oligomeric collagen gels to withstand a forced removal of 
a portion of the interstitial fluid phase, plastically creating materials with a much higher 
collagen fibril density and increased material properties.  
The densification technique created materials with controlled high level biophysical 
properties, including order of magnitude increases in elastic and compressive moduli, as 
well as increases in resistance to proteolytic degradation. The process was found to be 
amenable to cell encapsulation, creating high density cellularized tissue constructs which 
could impart controlled biomechanical cues to the encapsulated cells. 
The densified collagen oligomer materials were capable of withstanding a 
lyophilization procedure, and could be rehydrated without an effect on the mechanical or 
biochemical properties of the collagen by utilizing an ethanol rehydrating solution.  
The high-density collagen-fibril materials were found to have significantly higher elastic 
and compressive mechanical properties than a commercial, crosslinked, fibrillar collagen 
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sponge. The proteolytic degradation properties of the two materials were statistically 
similar, quite interesting considering the high-density collagen-fibril material contains no 
crosslinking to limit the biological activity of the collagen. Overall the high-density 
collagen-fibril material shows excellent promise as a clinical tool for tissue engineering 
applications. 
Overall, the materials created for this study provide the controllable 
microstructure and repeatability of polymerizable collagen, the natural biophysical 
signaling properties and mechanical properties of decellularized tissue, and the long term 
storage and ease of use of fibrillary collagen sponges, without the need for any 
exogenous crosslinking.  
4.2 Future Directions 
The mechanical integrity differences between the monomeric and oligomeric 
collagen formulations provide an outlook for further studies. In particular, a combination 
of monomeric collagens and oligomeric collagens combined with the densification 
technology explored here could create materials with high level collagen fibril densities 
with a range of material properties. This research could add a further level of individual 
property control for tissue engineering applications.  
The increased collagen density provided by the densification allows for the creation 
of cellularized in vitro tissue constructs for basic science studies. Because the cell-matrix 
interactions have a drastic effect on cell proliferation and differentiation, creation of an in 
vivo-like microstructure is paramount to an in vitro understanding of how cells behave in 
vivo. This technique, densification of oligomer collagen matrices, could allow for studies 
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of the effects of high collagen density microstructures on stem cell fate, or allow for the 
creation of more bone-like microstructures for study. In addition, this technology could 
allow for the creation of cryopreserved high density tissue constructs. 
In order to further examine the clinical potential of the high-density collagen-fibril 
materials, in vivo studies are necessary. Evaluating how the sponges fair in an in vivo 
environment with further elucidate the effects the branched fibril network and high 
collagen fibril density can have on wound healing.  
In addition, the effect of sterilization on the high-density collagen-fibril materials is 
necessary to evaluate how the biophysical properties change through this process. ETO 
sterilization is the current industry gold standard for collagen based products, and has 
been shown to have limited effects on the properties of the materials. So, it is likely that 
ETO sterilization will be adequate for use on the high-density collagen-fibril materials 











1. D. J. S. Hulmes, Journal of Structural Biology, 2002, 137, 2–10. 
2. F. W. K. Lisa D. Muiznieks, Biochimica et Biophysica Acta (BBA) - Molecular 
Basis of Disease, 2013, 1832, 866–875. 
3. E. A. Abou Neel, L. Bozec, J. C. Knowles, O. Syed, V. Mudera, R. Day and J. K. 
Hyun, Adv Drug Deliv Rev, 2013, 65, 429-456. 
4. Collagen - Structure and Mechanics | Springer, 2015. 
5. C. F. Whittington, E. Brandner, K. Y. Teo, B. Han, E. Nauman and S. L. Voytik-
Harbin, Microsc Microanal, 2013, 19, 1323-1333. 
6. S. Kreger, B. Bell, J. Bailey, E. Stites, J. Kuske, B. Waisner and S. Voytik-
Harbin, Biopolymers, 2010, 93, 690-707. 
7. A. M. Pizzo, K. Kokini, L. C. Vaughn, B. Z. Waisner and S. L. Voytik-Harbin, 
Journal of Applied Physiology, 2005, 98, 1909-1921. 
8. M. M. G. Guille, C. Helary, S. Vigier and N. Nassif, 2010, 6, 4963-4967. 
9. C. S. Hughes, L. M. Postovit and G. A. Lajoie, PROTEOMICS, 2015, 10, 1886-
1890. 
10. M. M. Giraud-Guille, International review of cytology, 1996, 166, 59-101. 
11. R. Brown, M. Wiseman, C. Chuo, U. Cheema and S. Nazhat, ADV FUNCT 
MATER , 15 (11) 1762 - 1770. (2005), 2005, 15, 986-992. 
12. M. Bitar, V. Salih, R. A. Brown and S. N. Nazhat, J Mater Sci Mater Med, 2007, 
18, 237-244. 
13. F. Moroni and T. Mirabella, Am J Stem Cells, 2014, 3, 1-20. 
14. Burns, 2003, 29, 837–841. 
15. M. Geiger, R. H. Li and W. Friess, Adv Drug Deliv Rev, 2003, 55, 1613-1629. 
16. L. Bessea, B. Coulomb, C. Lebreton-Decoster and M. M. Giraud-Guille, 
Biomaterials, 2002, 23, 27-36. 
17. B. A. Roeder, K. Kokini, J. E. Sturgis, J. P. Robinson and S. L. Voytik-Harbin, J 
Biomech Eng, 2002, 124, 214-222. 
18. J. L. Bailey, P. J. Critser, C. Whittington, J. L. Kuske, M. C. Yoder and S. L. 
Voytik-Harbin, Biopolymers, 2011, 95, 77-93. 
19. J. Lee, A. A. Abdeen, D. Zhang and K. A. Kilian, Biomaterials, 2013, 34, 8140-
8148. 
20. S. Khetan, M. Guvendiren, W. R. Legant, D. M. Cohen, C. S. Chen and J. A. 
Burdick, Nat Mater, 2013, 12, 458-465. 





22. S. M. Sweeney, J. P. Orgel, A. Fertala, J. D. McAuliffe, K. R. Turner, G. A. D. 
Lullo, S. Chen, O. Antipova, S. Perumal, L. Ala-Kokko, A. Forlino, W. A. 
Cabral, A. M. Barnes, J. C. Marini and J. D. S. Antonio, Journal of Biological 
Chemistry, 2008. 
23. D. J. Hulmes, A. Miller, D. A. Parry, K. A. Piez and J. Woodhead-Galloway, J 
Mol Biol, 1973, 79, 137-148. 
24. E. K. H. David L. Christiansen, Frederick H. Silver, Matrix Biology, 2000, 19, 
409–420. 
25. A. J. Bailey, R. G. Paul and L. Knott, Mech Ageing Dev, 1998, 106, 1-56. 
26. D. R. Eyre, M. A. Paz and P. M. Gallop, Annu Rev Biochem, 1984, 53, 717-748. 
27. L. C. Abraham, E. Zuena, B. Perez-Ramirez and D. L. Kaplan, J Biomed Mater 
Res B Appl Biomater, 2008, 87, 264-285. 
28. D. P. Knight, L. Nash, X. W. Hu, J. Haffegee and M. W. Ho, Journal of 
Biomedical Materials Research, 2015, 41, 185-191. 
29. W. G. C. and K. M. K., Biochemical Journal, 1960, 75, 588-598. 
30. A. O. Brightman, B. P. Rajwa, J. E. Sturgis, M. E. McCallister, J. P. Robinson 
and S. L. Voytik-Harbin, Biopolymers, 2000, 54, 222-234. 
31. S. T. K. a. S. L. Voytik-Harbin, Matrix Biology, 2009, 28, 336–346. 
32. J. L. Puetzer and L. J. Bonassar, Acta Biomaterialia, 2013, 9, 7787–7795. 
33. E. Bell, B. Ivarsson and C. Merrill, Proc Natl Acad Sci U S A, 1979, 76, 1274-
1278. 
34. K. R. Johnson, J. L. Leight and V. M. Weaver, Methods Cell Biol, 2007, 83, 547-
583. 
35. A. Nyga, M. Loizidou, M. Emberton and U. Cheema, Acta Biomater, 2013, 9, 
7917-7926. 
36. U. Cheema and R. Brown, Adv Wound Care (New Rochelle) , 2 (4) 176 - 184. 
(2013), 2013, 2, 176-184. 
37. M. Marotta and G. Martino, Anal Biochem, 1985, 150, 86-90. 
38. , ASTM Internation, West Conshohocken, PA, Editon edn., 2014. 
39. S. L. Voytik-Harbin, B. Rajwa and J. P. Robinson, Methods Cell Biol, 2001, 63, 
583-597. 
40. A. O. B. Sherry L. Voytik-Harbin, B.Z. Waisner,J. Paul Robinson,C.H. Lamar, 
Tissue Eng., 1998, 4, 157-174. 
41. J. M. Wallace, Q. Chen, M. Fang, B. Erickson, B. G. Orr and M. M. Banaszak 
Holl, Langmuir, 2010, 26, 7349-7354. 
42. D. T. Woodley, M. Yamauchi, K. C. Wynn, G. Mechanic and R. A. Briggaman, J 
Invest Dermatol, 1991, 97, 580-585. 
43. K. Gelse, E. Poschl and T. Aigner, Adv Drug Deliv Rev, 2003, 55, 1531-1546. 
44. W. Friess, Eur J Pharm Biopharm, 1998, 45, 113-136. 
45. D. P. Speer, M. Chvapil, C. D. Eskelson and J. Ulreich, Journal of Biomedical 
Materials Research, 2015, 14, 753-764. 
46. P. Angele, J. Abke, R. Kujat, H. Faltermeier, D. Schumann, M. Nerlich, B. 





47. I. V. Yannas, J. F. Burke, C. Huang and P. L. Gordon, J Biomed Mater Res, 1975, 
9, 623-628. 
48. J. M. Gimble and F. Guilak, http://dx.doi.org/10.1080/14653240310003026, 
2009, 5, 362-369. 
49. F. Guilak, K. E. Lott, H. A. Awad, Q. Cao, K. C. Hicok, B. Fermor and J. M. 
Gimble, Journal of Cellular Physiology, 2015, 206, 229-237. 
50. P. Carinci, M. Bodo, R. Evangelisti and E. Becchetti, Ital J Anat Embryol, 1995, 
100 Suppl 1, 65-74. 
51. S. Rhee and F. Grinnell, Adv Drug Deliv Rev, 2007, 59, 1299-1305. 
52. A. M. Pizzo, K. Kokini, L. C. Vaughn, B. Z. Waisner and S. L. Voytik-Harbin, J 
Appl Physiol (1985), 2005, 98, 1909-1921. 
53. Advanced Drug Delivery Reviews, 2003, 55, 1531–1546. 
54. S. M. Sweeney, J. P. Orgel, A. Fertala, J. D. McAuliffe, K. R. Turner, G. A. D. 
Lullo, S. Chen, O. Antipova, S. Perumal, L. Ala-Kokko, A. Forlino, W. A. 
Cabral, A. M. Barnes, J. C. Marini and J. D. S. Antonio, Journal of Biological 
Chemistry, 2008, 283, 21187-21197. 
55. Mechanisms of Ageing and Development, 1998, 106, 1–56. 
56. O. Singh, S. S. Gupta, M. Soni, S. Moses, S. Shukla and R. K. Mathur, J Cutan 
Aesthet Surg, 2011, 4, 12-16. 
57. K. G. Cornwell, A. Landsman and K. S. James, Clinics in Podiatric Medicine and 
Surgery, 2009, 26, 507-523. 
58. M. McClure, G. D. Duncan, G. V. Born and F. Robicsek, Haemostasis, 1987, 17, 
349-352. 
59. C. Neu and G. Genin, Handbook of Imaging in Biological Mechanics, CRC Press, 
2014. 
60. D. A. F. F. Ysabel M. Bello, William H. Eaglstein, American Journal of Clinical 
Dermatology, 2012, 2, 305-313. 
61. W. R. Wagner, J. M. Pachence, J. Ristich and P. C. Johnson, J Surg Res, 1996, 
66, 100-108. 
62. ASTM, Editon edn., 1986. 
63. D. O. Freytes, R. S. Tullius and S. F. Badylak, Journal of Biomedical Materials 
Research Part B: Applied Biomaterials, 2015, 78B, 327-333. 
64. G. Vazquez, E. Alvarez and J. M. Navaza, 2002, 40, 611-614. 
65. S. V. Madihally and H. W. Matthew, Biomaterials, 1999, 20, 1133-1142. 
66. R. Roeder, J. Wolfe, N. Lianakis, T. Hinson, L. A. Geddes and J. Obermiller, 
Journal of Biomedical Materials Research, 2015, 47, 65-70. 
67. K. Billiar, J. Murray, G. Abraham and N. Bachrach, Journal of Biomedical 
Materials Research, 2015, 56, 101-108. 
68. T. M. F. Donna Schulz Torres, Ioannis V Yannas, Myron Spector, Biomaterials, 
2000, 21, 1607–1619. 
69. Advanced Drug Delivery Reviews, 2003, 55, 1613–1629. 
 
 
 
